NL-OMON36008已完成不适用
The physiological role of bile acid*mediated glucagon*like peptide*1 release in humans: the Cerebrotendinous Xanthomatosis Mixed Meal Test study -
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •*Adult age (older than 18 years of age)
- •*Body mass index 19*30 kg/m2
- •*General good health (normal liver and renal function)
- •*HbA1c below 7%
- •*Ability to give informed consent
排除标准
- •Since CTX is a rare disorder, little exclusion criteria exist. However, patients that use
- •medication that interferes with glucose metabolism such as oral antidiabetic medication or
- •insulin are not included.
研究者
相似试验
尚未招募
不适用
The physiological role of bile acid‐mediated glucagon‐like peptide‐1 release in humans: The Cerebrotendinous Xanthomatosis Mixed Meal Test study.NL-OMON23193AMC28
招募中
不适用
The effect of the secondary bile acid glycodeoxycholic acid as a therapy for diabetes.NL-OMON20316Academic Medical Center (AMC), Amsterdam, The Nettherlands40
进行中（未招募）
1 期
The effect of the secondary bile acid glycodeoxycholic acid as a therapy for diabetes.Type 2 diabetes mellitusMedDRA version: 20.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2017-002079-24-NLAcademic Medical Center40
已完成
不适用
Targeting the secondary bile acid glycodeoxycholic acid as therapeutic strategy in type 2 diabetes mellitus.NL-OMON55800Academisch Medisch Centrum40
招募中
不适用
Characterization of intestinal bile acid metabolim in children with inflammatory bowel diseaseK50K51Crohn disease [regional enteritis]Ulcerative colitisPediatric inflammatory bowel diseaseDRKS00003580niversitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz75